The domains of the 8 consensus statements can be broadly categorized into the use of hypoallergenic formulas when breastmilk is not available or insufficient, eHF in IgE and non-IgE mediated allergy, the position of HRF in the management of CMA, and safety and growth of these formulas. Here, IGHE is linked to allergic disease.